HA+
LIVE

Serial Number

98767760

Owner

Axogen Corporation

Attorney

John Zaccaria

First Use Date

Dec 5, 2022

Filing Date

Sep 25, 2024

Add to watchlist:

No watchlists yet
View on USPTO

HA+ Trademark

Serial Number: 98767760

HA+ is a trademark filed by Axogen Corporation on September 25, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Axogen Corporation

111 W. Oak Avenue, 5th Floor
Tampa, FL 33602

Entity Type: 03

Trademark Details

Filing Date

September 25, 2024

Registration Date

Not Registered

First Use Anywhere

December 5, 2022

First Use in Commerce

May 12, 2023

Goods & Services

Implants comprising living tissue; Implants comprising biological tissue and chemical preparations, composed of a combination of sodium hyaluronate and sodium alginate, for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising biological tissue

Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising natural, non-living material; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising synthetic material

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 24, 2026 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 21, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 21, 2025 GNSL
SUSPENSION LETTER WRITTEN
Oct 21, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 20, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 20, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 31, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 31, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 31, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 31, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 30, 2025 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 23, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 23, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 23, 2024 REAP
NEW APPLICATION ENTERED
Sep 25, 2024 NWAP